So, we all get spam. Penny stocks and Viagra being the most common in my inbox and this was at the bottom of an otherwise regular penny stock ad.
Submitted for your wtf:
I showed him all the documentation, all the emails, and the reports that I've written. For example, working at the FDA, is their pay somehow based on how many drugs they approve? He who pays the piper calls the tune, and we now have a captured agency.
I don't think that people come away with it and they certainly don't come away with any sense of how likely it is to happen because the visual image overpowers anything that gets said.
Physicians don't read product labels.
A company may come in with a drug and want to get it approved for five different indications.
Obviously he had been tipped off by people in the Senate Finance Committee who are sympathetic to the FDA's status quo that I was going to be called as a witness.
For example, working at the FDA, is their pay somehow based on how many drugs they approve?
GRAHAM: It did in so far as my faith forms my conscience.
How many people are actually benefiting?
GRAHAM: At this current moment I don't think there are other drugs out there that are as bad as Vioxx in terms of the enormous numbers of people that were hurt.
However, if you were to read the labeling for these drugs it doesn't point that fact out so patients think one SSRI is as good as another.
Industry money is influencing the decisions that get made, and it creates this incentive structure.
It's not saying I'm a saint, because I'm not. And it's all because of this little pill that they're taking. This high-level FDA official never talked to me about this allegation. All the other SSRI antidepressants are no better than sugar pills. Industry pays the fee, and the FDA will review the drug application.
The FDA has never looked at benefit. But the FDA didn't want to do that because it would interfere with company profits.
Submitted for your wtf:
I showed him all the documentation, all the emails, and the reports that I've written. For example, working at the FDA, is their pay somehow based on how many drugs they approve? He who pays the piper calls the tune, and we now have a captured agency.
I don't think that people come away with it and they certainly don't come away with any sense of how likely it is to happen because the visual image overpowers anything that gets said.
Physicians don't read product labels.
A company may come in with a drug and want to get it approved for five different indications.
Obviously he had been tipped off by people in the Senate Finance Committee who are sympathetic to the FDA's status quo that I was going to be called as a witness.
For example, working at the FDA, is their pay somehow based on how many drugs they approve?
GRAHAM: It did in so far as my faith forms my conscience.
How many people are actually benefiting?
GRAHAM: At this current moment I don't think there are other drugs out there that are as bad as Vioxx in terms of the enormous numbers of people that were hurt.
However, if you were to read the labeling for these drugs it doesn't point that fact out so patients think one SSRI is as good as another.
Industry money is influencing the decisions that get made, and it creates this incentive structure.
It's not saying I'm a saint, because I'm not. And it's all because of this little pill that they're taking. This high-level FDA official never talked to me about this allegation. All the other SSRI antidepressants are no better than sugar pills. Industry pays the fee, and the FDA will review the drug application.
The FDA has never looked at benefit. But the FDA didn't want to do that because it would interfere with company profits.